TAYDMEDIUM SIGNALFINANCIAL10-K

TAYD dramatically reduced share buyback activity while experiencing weakened operating cash flow generation and a substantial decline in cash reserves.

The company's shift from $9.9M to just $201K in share buybacks alongside reduced operating cash flow suggests either capital allocation discipline or cash flow constraints. The customer concentration remains high but shows some stability, with three customers representing 42% of sales compared to four customers at 40% previously.

Comparing 2025-08-15 vs 2024-08-15View on EDGAR →
FINANCIAL ANALYSIS

TAYD's balance sheet shows mixed signals with total assets growing modestly to $71.6M and stockholders equity increasing 21% to $62M, while cash reserves declined meaningfully to $1.2M from $2.8M. Operating cash flow weakened notably to $7.5M, and the company pulled back significantly on share repurchases. The overall picture suggests the company is preserving cash while maintaining growth investments, though the reduced liquidity position warrants monitoring.

FINANCIAL STATEMENT CHANGES
Share Buybacks
Cash Flow
-98%
$9.9M$201K

Buyback activity reduced 98% — capital being redeployed elsewhere or cash conservation underway.

Cash & Equivalents
Balance Sheet
-57.9%
$2.8M$1.2M

Cash declined 57.9% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Operating Cash Flow
Cash Flow
-43.5%
$13.2M$7.5M

Operating cash flow fell 43.5% — earnings quality concerns; investigate working capital changes and non-cash items.

Stockholders Equity
Balance Sheet
+21.1%
$51.2M$62.0M

Equity base grew 21.1% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Current Liabilities
Balance Sheet
-19.1%
$11.8M$9.6M

Current liabilities reduced — improved short-term financial position and working capital health.

Current Assets
Balance Sheet
+15.4%
$48.8M$56.3M

Current assets grew 15.4% — improving short-term liquidity or inventory/receivables build.

R&D Expense
P&L
+14.3%
$388K$444K

R&D investment increased 14.3% — signals commitment to future product development, though near-term margin impact.

Total Assets
Balance Sheet
+13.5%
$63.1M$71.6M

Asset base grew 13.5% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2025-08-15
PRIOR — 2024-08-15
ADDED
(Exact name of registrant as specified in its charter) New York 16-0797789 (State or other jurisdiction of incorporation or organization) (I.R.S.
From time to time, the Company uses the services of non-employee sales representatives for sales throughout the rest of the world.
The Company recorded zero and $77,000 of non-employee commission expense for the years ending May 31, 2025 and 2024 respectively.
Dependence Upon Major Customers Sales to three customers accounted for approximately 42% (21%, 15% and 6%, respectively) of our net sales for 2025.
Sales to four customers accounted for approximately 40% (21%, 7%, 7% and 5%, respectively) of our net sales for 2024.
+7 more — sign up free →
REMOVED
The Company uses the services of several non-employee sales representatives for sales throughout the rest of the world.
Dependence Upon Major Customers Sales to four customers approximated 40% (21%, 7%, 7%, and 5%, respectively) of net sales for 2024.
Patents, Trademarks and Licenses The Company holds ten patents expiring at different times until the year 2040.
Terms of Sale The Company does not carry significant inventory for rapid delivery to customers, and goods are not normally sold with return rights such as are available for consignment sales.
The Company had no inventory out on consignment and there were no consignment sales for the years ended May 31, 2024 and 2023.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →